NEWS AND VIEWS
01 July 2026
Evolutionarily conserved targets have been identified that are shared across malaria-parasite species and their life stages and are recognized by the human immune system.
By
Denise L. Doolan
Denise L. Doolan is at the Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland 4072, Australia.
Carla Proietti
Carla Proietti is at the Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland 4072, Australia.
The quest to develop a malaria vaccine has been frustrated by a simple problem: researchers have limited knowledge about which parasite proteins the human immune system recognizes during infection. Most vaccine targets have therefore been chosen on the basis of indirect evidence or similarity to proteins from other microbes. Writing in Nature, Barbosa et al.1 address this knowledge gap. Studying the malaria parasite Plasmodium vivax, the authors mapped the protein fragments (antigens) that are presented to immune cells during human infection. This revealed a previously hidden landscape of malaria targets that are associated with protective immune responses in humans, monkeys and mice. These targets are evolutionarily conserved across Plasmodium species and are expressed at various stages of the parasite life cycle.
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
27,99 € / 30 days
cancel any time
Subscribe to this journal
Receive 52 print issues and online access
185,98 € per year
only 3,58 € per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Log in
Learn about institutional subscriptions
Read our FAQs
Contact customer support
doi: https://doi.org/10.1038/d41586-026-01808-x
References
Barbosa, C. R. R. et al. Nature https://doi.org/10.1038/s41586-026-10730-1 (2026).
Article
Google Scholar
World Health Organization. World Malaria Report 2025 (WHO, 2025).
Duffy, P. E., Gorres, J. P., Healy, S. A. & Fried, M. Nature Rev. Microbiol. 22, 756–772 (2024).
Article
PubMed
Google Scholar
Moorthy, V., Hamel, M. J. & Smith, P. G. Lancet 403, 504–505 (2024).
Article
PubMed
Google Scholar
Datoo, M. S. et al. Lancet 403, 533–544 (2024).
Article
PubMed
Google Scholar
Junqueira, C. et al. Nature Med. 24, 1330–1336 (2018).
Article
PubMed
Google Scholar
Valencia-Hernandez, A. M. et al. Cell Host Microbe 27, 950–962 (2020).
Article
PubMed
Google Scholar
Walters, L. C. et al. Nature Commun. 9, 3137 (2018).
Article
PubMed
Google Scholar
Bassani-Sternberg, M. & Coukos, G. Current Opin. Immunol. 41, 9–17 (2016).
Article
Google Scholar
Leddy, O. K., White, F. M. & Bryson, B. D. mSystems 6, e00310-21 (2021).
Article
PubMed
Google Scholar
Download references
Competing Interests
The authors declare no competing interests.
Related Articles
Read the paper: Identification of cross-stage, cross-species malaria CD8+ T cell antigens
Climate shocks, not just warming, threaten malaria control efforts in Africa
Genetically engineered mosquitoes block development of circulating malaria strains
See all News & Views
Subjects
Latest on:
Identification of cross-stage, cross-species malaria CD8+ T cell antigens
Article 01 JUL 26
Ebola preparedness must start with ecosystems and before humans show symptoms
Correspondence 30 JUN 26
Vaccination elicits HIV broadly neutralizing antibodies in primates
Article 30 JUN 26
Cancer Research UK bets on Manchester with £6-million funding boost
Career News 01 JUL 26
Identification of cross-stage, cross-species malaria CD8+ T cell antigens
Article 01 JUL 26
N4-Acetylcytidine enhances synthetic mRNA translation yield and fidelity
Article 01 JUL 26
Identification of cross-stage, cross-species malaria CD8+ T cell antigens
Article 01 JUL 26
Vaccines mean malaria deaths should be falling — not rising
Editorial 21 APR 26
Climate shocks, not just warming, threaten malaria control efforts in Africa
News & Views 03 MAR 26
View original source — Nature ↗

